Smartphone app to track thyroid eye disease during treatment
Part of Eyes & vision, Genetic & congenital, Hormones & metabolism, Immune system & allergy clinical trials.
This study tests whether a smartphone app that uses artificial intelligence (AI) can help you monitor your thyroid eye disease (TED) during non-surgical treatment. You will take regular selfies and answer questions to see if the app helps track your symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older and have been diagnosed with thyroid eye disease (TED).
- You are about to start a non-surgical treatment for TED, such as steroids, radiation, or biologic therapy.
- You can attend a clinic visit before starting treatment and at least one follow-up visit during treatment.
- You have a smartphone and are willing to use it to take standardized selfies of your face and answer a symptom questionnaire every week.
- You have not had eye, eyelid, or eye socket surgery in the last 3 months, and surgery is not your main planned treatment now.
- Your face does not have severe deformities that would interfere with the app's facial analysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people newly diagnosed with Graves' disease to see who might develop thyroid eye disease, a condition that can affect the eyes. It aims to find early signs so that treatment can be started sooner.
This study tests a new medication called GenSci098 for people with active thyroid eye disease. It aims to reduce eye symptoms like redness, swelling, and bulging, and improve quality of life.
This study tests an investigational medication for thyroid eye disease, which causes bulging eyes and discomfort. The treatment is given as an injection near the eye, and the study will last about 12 months to see how safe and effective it is.
This trial tests a new medicine called MHB018A for people with active thyroid eye disease (TED), a condition that causes the eyes to bulge and become inflamed. The study aims to see if the drug can reduce symptoms and improve eye appearance compared to a placebo.
This study uses MRI scans of the eye area to better understand and classify thyroid eye disease (TED). It aims to help doctors predict outcomes and personalize treatment. You may be eligible if you have stable TED or are a healthy volunteer.
This study uses eye tracking to compare how people with thyroid eye disease move their eyes and pay attention to visual cues. It may help researchers understand eye movement problems better.
Hear when a new Thyroid Eye Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.